Literature DB >> 18922133

Janus kinases promote cell-surface expression and provoke autonomous signalling from routing-defective G-CSF receptors.

Annemarie Meenhuis1, Mahban Irandoust, Albert Wölfler, Onno Roovers, Marijke Valkhof, Ivo P Touw.   

Abstract

CSF3R [G-CSF (granulocyte colony-stimulating factor) receptor] controls survival, proliferation and differentiation of myeloid progenitor cells via activation of multiple JAKs (Janus kinases). In addition to their role in phosphorylation of receptor tyrosine residues and downstream signalling substrates, JAKs have recently been implicated in controlling expression of cytokine receptors, predominantly by masking critical motifs involved in endocytosis and lysosomal targeting. In the present study, we show that increasing the levels of JAK1, JAK2 and TYK2 (tyrosine kinase 2) elevated steady-state CSF3R cell-surface expression and enhanced CSF3R protein stability in haematopoietic cells. This effect was not due to inhibition of endocytotic routing, since JAKs did not functionally interfere with the dileucine-based internalization motif or lysine-mediated lysosomal degradation of CSF3R. Rather, JAKs appeared to act on CSF3R in the biosynthetic pathway at the level of the ER (endoplasmic reticulum). Strikingly, increased JAK levels synergized with internalization- or lysosomal-routing-defective CSF3R mutants to confer growth-factor independent STAT3 (signal transducer and activator of transcription 3) activation and cell survival, providing a model for how increased JAK expression and disturbed intracellular routing of CSF3R synergize in the transformation of haematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18922133     DOI: 10.1042/BJ20081153

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signaling.

Authors:  Jonathan T Lei; Tuhina Mazumdar; Margarita Martinez-Moczygemba
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

2.  Fos-Zippered GH Receptor Cytosolic Tails Act as Jak2 Substrates and Signal Transducers.

Authors:  Tobias Nespital; Lieke M van der Velden; Anneloes Mensinga; Elisabeth D van der Vaart; Ger J Strous
Journal:  Mol Endocrinol       Date:  2016-02-09

Review 3.  Targeting the interleukin-6/Jak/stat pathway in human malignancies.

Authors:  Pasquale Sansone; Jacqueline Bromberg
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

4.  Determinants of the extent and duration of STAT3 signaling.

Authors:  Bernd Groner
Journal:  JAKSTAT       Date:  2012-07-01

5.  Jak2 is a negative regulator of ubiquitin-dependent endocytosis of the growth hormone receptor.

Authors:  Joyce Putters; Ana C da Silva Almeida; Peter van Kerkhof; Agnes G S H van Rossum; Ana Gracanin; Ger J Strous
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

Review 6.  Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.

Authors:  Ping-Hung Chen; Huiyu Yao; Lily Jun-Shen Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-01       Impact factor: 5.555

Review 7.  Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.

Authors:  Salem H Alshemmari; Reshmi Rajan; Ashkan Emadi
Journal:  Med Princ Pract       Date:  2016-09-21       Impact factor: 1.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.